Clinical Trial

A Multicenter Study on the Normal Reference Range and Clinical Significance of the Right Atrioventricular Coupling Index Assessed by Artificial Intelligence-Based Three-Dimensional Echocardiography

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This multicenter study aims to establish the normal reference range of the Right Atrioventricular Coupling Index (RACI) in healthy Chinese adults using AI-based 3DE technology. It will also analyze the correlation between RACI and physiological parameters such as age, gender, and body surface area. Additionally, the study will explore the variation characteristics of RACI in patients with pulmonary hypertension, heart failure, tricuspid regurgitation, and atrial septal defect, and evaluate the clinical value of RACI in disease diagnosis, differential diagnosis, and risk stratification.
Trial Details
NCT Number NCT07292896
Lead Sponsor First Hospital of China Medical University
Conditions Healthy Adults, Pulmonary Hypertension, Tricuspid Regurgitation, Heart Failure, Atrial Septal Defect
Enrollment 2,640 participants
Start Date 2025-12
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-18